ArticleRecent patents on anti-cancer drug discovery2026

Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway.

Hui-Hui Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.